Clinical Trial Update: A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating all-trans retinoic acid (ATRA) in a novel drug combination for pancreatic cancer; the trial is currently active but not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• ATRA (all-trans retinoic acid)

Snippet

Sponsor: Queen Mary University of London | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING